Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07017595 · ClinicalTrials.gov registry record · NA
Gender-affirming Voice Training With Visual Feedback
A NA study, sponsored by University of Cincinnati.
- Terminated
- Registry status
- NA
- Development phase
- 6
- Enrollment target
NCT07017595: Clinical Trial NA study, sponsored by University of Cincinnati.
NCT07017595 is a NA study that was terminated before completion, run by University of Cincinnati. The registered enrollment target is 6 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (100% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT07017595, a NA study, was terminated before completion, sponsored by University of Cincinnati.
- TERMINATED
- Registry status
- NA
- Development phase
- 6 participants
- Enrollment target
Study Summary
The goal of this clinical trial is to learn if prototype software can be used to train vocal pitch and resonance in trans women. The main questions it aims to answer are: * How regularly would trans women use the prototype voice training software as "homework" between human-led voice training sessions? * In such a setting, how usable and motivating would the training software be? Participants will first have their voice measured, then take part in four virtual sessions (one per week) led by a speech-language pathologist. In each session, the clinician will guide the participant through several voice exercises both with and without the software. Participants will be asked to use the software to exercise on their own for about 2x 15 minutes a day between virtual sessions.
Primary Outcome
The IMI is a patient-reported outcome measure that collects information about participants' experience of interacting with a particular task or technology. The total instrument consists of 45 items under seven subcategories (Interest/Enjoyment, Perceived Competence, Effort/Importance, Pressure/Tension, Perceived Choice, Value/Usefulness, and Relatedness). We will use an 8-item version of the scale that has been adopted in previous lab-based studies on motivation, including several by our group.
Interventions
- BEHAVIORAL Visual-acoustic biofeedback: experimental
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 6 participants |
| Start Date | 2025-06-05 |
| Est. Completion | 2025-07-18 |
| Phase | NA |
Why NCT07017595 stopped before completion
NCT07017595 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 6 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (100% lower).
The record links to 0 conditions, and to 1 intervention - of which Visual-acoustic biofeedback: experimental is the first listed.
NCT07017595 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT07017595 about?
NCT07017595 is a clinical study titled "Gender-affirming Voice Training With Visual Feedback". The goal of this clinical trial is to learn if prototype software can be used to train vocal pitch and resonance in trans women. The main questions it aims to answer are: * How regularly would trans women use the prototype voice training software as "homework" between human-led voice training sessi...
What is the current status of trial NCT07017595?
This trial is currently terminated. It is a NA study. The enrollment target is 6 participants. The study started on 2025-06-05. Estimated completion is 2025-07-18.
What interventions are being tested in trial NCT07017595?
The interventions under investigation include: Visual-acoustic biofeedback: experimental (BEHAVIORAL).
Who is sponsoring clinical trial NCT07017595?
This trial is sponsored by University of Cincinnati, which has 245 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT07017595's enrollment target sits among peer trials
6 1983rd of 2000 higher than 13 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI